We’ve done a lot of work on quality improvement, such as enhancing recovery, reducing intestinal injury during and after surgery, and reducing infections after surgery, explained William Cliby, MD, consultant, division of gynecologic surgery, department of obstetrics & gynecology, Mayo Clinic.
We’ve done a lot of work on quality improvement, such as enhancing recovery, reducing intestinal injury during and after surgery, and reducing infections after surgery, explained William Cliby, MD, consultant, division of gynecologic surgery, department of obstetrics & gynecology, Mayo Clinic.
Transcript
What surgical quality improvement measure have you focused on to improve surgical outcomes for patients with ovarian cancer?
For us, it’s taken 2 shapes. One is to reduce the amount of residual disease in the patient at the end of their first surgery. We think that puts them in the best position to respond to chemotherapy. So, we’ve spent a lot of effort at our own place and the Society of Gynecologic Oncology has, as well, to try to improve the surgical quality. Leaving less residual disease, using upper abdominal resection techniques to get the best quality surgery.
More specifically, to the actual surgical event, is steps to reduce the complications after surgery. We’ve done a lot of work on quality improvement, whether it’s enhanced recovery, so faster recovery for patients, reducing intestinal injury during and after surgery, reducing infections after surgery as well. All of those things have allowed us to reduce our complication rate and so reduce the amount of poor outcomes relative to good outcomes.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More